Objectives The study herein aimed to assess the prevalence of type 2 diabetes mellitus
(T2DM), impaired fasting glucose (IFG), as well as general and abdominal obesity in …

Background Overweight and obesity are major causes of comorbidities which can lead to
further morbidity and mortality. The main objective of the present study was to estimate the …

Background Bipolar disorder (BD) has been associated with cognitive impairment during
depressed, manic and euthymic periods. Inflammation has been shown to be involved in the …

Background: Metabolic syndrome (MetS) is more prevalent in individuals with bipolar
disorder and has a negative impact on cognition, in particular on executive function, which is …

Objective Epidemiological data have shown a clear association between bipolar disorder
(BD) and medical comorbidities. The aim of this article was to assess the evidence of …

Background Several epidemiological studies have found that the prevalence of bipolar
disorder (BD) is significantly higher in obese population than non-obese population …

Cognitive impairment is a major source of disability in schizophrenia and current
antipsychotic drugs (APDs) have minimal efficacy for this symptom domain. Cannabidiol …

We performed an updated review of the available literature on weight gain and increase of
body mass index (BMI) among children and adolescents treated with antipsychotic …

A number of studies have reported that patients with schizophrenia have a higher body
mass index (BMI) than the general population. Few Asian studies have examined BMI in …

Objectives The Bipolar Disorders: Improving Diagnosis, Guidance and Education (BRIDGE)‐
II‐Mix study aimed to estimate the frequency of mixed states in patients with a major …